Skip to main content
. 2017 May 9;22(7):786–796. doi: 10.1634/theoncologist.2016-0458

Table 4. Trials evaluating targeted therapies in BRAF‐mutant non‐small cell lung cancer.

image

Abbreviations: BRAF, B‐Raf proto‐oncogene, serine/threonine kinase; CSF‐1, colony stimulating factor 1; ERK, extracellular signal‐regulated kinase; MEK, mitogen‐activated protein kinase kinase.